Therapeutic Goods (Poisons Standard—October 2024) Instrument 2024
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Therapeutic Goods (Poisons Standard—October 2024) Instrument 2024
Start here
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Poisons Standard—October 2024) Instrument 2024.
39 Exemptions from label requirements in certain circumstances
(1) A requirement specified in Subdivision B or section 35 or 37 does not apply to a poison if an appropriate authority has granted a labelling exemption under this subsection in relation to that requirement for the poison.
(2) A labelling exemption granted by an appropriate authority under subsection (1) remains in force:
(a) if the exemption relates to a product that is indicated for the treatment or prevention of the coronavirus known as COVID‑19:
(i) for the period specified in the exemption; or
(ii) if no period is specified—until revoked by the appropriate authority; or
(b) in any other case:
(i) for the period, specified in the exemption, that is 12 months or less from the date of commencement of the exemption; or
(ii) if no period is specified—12 months from the date of commencement of the exemption.
(3) For the avoidance of doubt, this section does not apply to an authorisation given under subparagraph 28(d)(iii).